Colchicine and Inflammation in Hemodialysis Patients

Summary

Chronic, low-grade inflammation is regarded as a common comorbid condition in chronic dialysis patients. Increased inflammatory markers in chronic dialysis patients are associated with adverse clinical outcomes . Considering the association of low-grade inflammation with high rate of morbidity and mortality we decided to evaluate the anti inflammatory effect of colchicine on inflammatory markers in hemodialysis patients

Timeline

Start

2022-11-01

Primary completion

2023-02

Completion

2023-02

Drugs

Indications